Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Leukemia, Myeloid, Acute 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 17Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Hodgkin Disease 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Leukemia, Lymphocytic, Chronic, B-Cell 10Myeloproliferative Disorders 9Melanoma 8Recurrence 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Biphenotypic, Acute 7Anemia, Refractory, with Excess of Blasts 7Lymphoma 6Leukemia 6Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Waldenstrom Macroglobulinemia 4Neuroblastoma 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Juvenile 4Hematologic Neoplasms 4Colorectal Neoplasms 4Burkitt Lymphoma 4Uveal Melanoma 3Stomach Neoplasms 3Primary Myelofibrosis 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Etoposide 3Carboplatin 3pembrolizumab 2fludarabine phosphate 2fludarabine 2Paclitaxel 2Cyclophosphamide 2Cisplatin 2repotrectinib 1pralsetinib 1lutetium Lu 177 dotatate 1Vorinostat 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Pemetrexed 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Ifosfamide 1Gemcitabine 1Cytapheresis 1Bleomycin 1Biopsy 1Automobiles 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × fludarabine phosphate × 90 days × Clear all
NCT04897321 2026-05-19

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

St. Jude Children's Research Hospital

Phase 1 Recruiting
48 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Adrenal Cortex Neoplasms, Carcinoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Neurofibrosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

NCT05092451 2026-05-06

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
80 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡